Preventing Epidemics of HIV-1 among Injecting Drug Users

Don C. Des Jarlais, Holly Hagan, Samuel R. Friedman, Patricia Friedmann, David Goldberg, Martin Frischer, Steven Green, Kerstin Tunving, Bengt Ljungberg, Alex Wodak, Michael Ross, David Purchase, Peggy Millson, Ted Myers

Research output: Chapter in Book/Report/Conference proceedingChapter

1 Scopus citations

Abstract

In many areas, the spread of HIV-1 among injecting drug users (IDUs) due to the multi-person use of drug injection equipment has occurred with extreme rapidity. In New York City, for example, HIV-1 seroprevalence among IDUs increased from under 10 per cent to over 50 per cent in a period of five years (Des Jarlais et al., 1989); in Edinburgh, HIV-1 seroprevalence among IDUs increased from zero to over 40 per cent in one year (Robertson et al., 1986); in Bangkok, HIV-1 seroprevalence increased from 2 per cent to over 40 per cent in two years (Vanichseni and Sakuntanaga, 1990); and in the state of Manipur, India, levels increased from zero to approximately 50 per cent in one year (Naik et al., 1991). HIV-1 has spread rapidly among populations where there has been a lack of awareness of AIDS as a local threat and mechanisms such as ‘shooting galleries’, ‘dealer’s works’ and professional injectors that provide rapid and efficient mixing among large numbers of IDUs (Friedman and Des Jarlais, 1991).

Original languageEnglish (US)
Title of host publicationWorld Health Organization
Subtitle of host publicationDrug Injecting and HIV Infection: Global Dimensions and Local Responses
PublisherTaylor and Francis
Pages183-200
Number of pages18
ISBN (Electronic)9781135359546
ISBN (Print)9781857288247
DOIs
StatePublished - Jan 1 2003
Externally publishedYes

ASJC Scopus subject areas

  • General Health Professions
  • General Medicine

Fingerprint

Dive into the research topics of 'Preventing Epidemics of HIV-1 among Injecting Drug Users'. Together they form a unique fingerprint.

Cite this